Yanjun Xu
- Health, Toxicology and Mutagenesis top 2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Topics
- Lung Cancer Treatments and Mutations (25 papers)Lung Cancer Research Studies (18 papers)Cancer Immunotherapy and Biomarkers (16 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yanjun Xu
83 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 128
- Health, Toxicology and Mutagenesis 527
- Oncology 489
- Pulmonary and Respiratory Medicine 439
- Molecular Biology 257
- Cancer Research 186
Countries citing papers authored by Yanjun Xu
This map shows the geographic impact of Yanjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Xu more than expected).
Fields of papers citing papers by Yanjun Xu
This network shows the impact of papers produced by Yanjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Xu. The network helps show where Yanjun Xu may publish in the future.
Co-authorship network of co-authors of Yanjun Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yanjun Xu. A scholar is included among the top collaborators of Yanjun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjun Xu. Yanjun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 10 | |
| 4 | 14 | |
| 5 | 8 | |
| 6 | ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics | 1 |
| 7 | 20 | |
| 8 | 2 | |
| 9 | 45 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | [The impact of temperature on cardiovascular disease deaths in 4 cities, China: a time-series study]. | 3 |
| 13 | 10 | |
| 14 | Incidence of unsafe driving behaviors and its related risk factors | 2 |
| 15 | Investigation on drinking behaviors among inhabitants aged over 15 years in Guangdong province | 1 |
| 16 | Analysis on nutrition status of infants under 24 months in Guangdong province | 1 |
| 17 | The study on dietary intake and nutritional status of residents in Guangdong, 2002 | 12 |
| 18 | Analysis on epidemiological characteristics of central obesity of population aged eighteen and over in Guangdong Province in 2002 | 1 |
| 19 | Analysis on injury among pre-school children in Guangdong province | 1 |
| 20 | Anemia epidemiological features and determinants in Guangdong province, 2002 | 2 |
About Yanjun Xu
Yanjun Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis, having authored 88 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (18 papers) and Cancer Immunotherapy and Biomarkers (16 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (527 citations), Oncology (489 citations) and Pulmonary and Respiratory Medicine (439 citations). Yanjun Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenjun Ma, Xiaojun Xu, Zhiyu Huang, Yuan Luo, Weilin Zeng, Wei Wu, Jianpeng Xiao, Yun Fan, Tao Liu and Kaiyan Chen. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.